Document Detail

Concentration-dependent effects of tiludronate on equine articular cartilage explants incubated with and without interleukin-1β.
MedLine Citation:
PMID:  23013178     Owner:  NLM     Status:  In-Data-Review    
Objective-To determine concentration-dependent effects of tiludronate on cartilage explants incubated with or without recombinant equine interleukin-1β (rEq IL-1). Sample-Articular cartilage explants from the femorotibial joints of 3 young adult horses. Procedures-Cartilage explants were incubated with 1 of 6 concentrations (0, 0.19, 1.9, 19, 190, or 1,900 mg/L) of tiludronate and with or without rEq IL-1 (0.01 ng/mL) for 96 hours. Prostaglandin E(2) (PGE(2)) concentrations in culture medium and explant digests were analyzed via PGE(2) enzyme immunoassay. Sulfated glycosaminoglycan (sGAG) concentrations in culture medium were quantified via 1,9-dimethylmethylene blue assay. Chondrocyte apoptosis in paraffin embedded explant sections was measured via terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling assay. Relative gene expression of matrix metalloproteinases (MMPs), interleukin (IL)-6, and IL-8 was determined via the comparative cycle threshold method. Results-rEq IL-1 increased PGE(2) concentration, sGAG release from explants, chondrocyte apoptosis, and MMP gene expression. Lower tiludronate concentrations reduced rEq IL-1-induced sGAG release and chondrocyte apoptosis, whereas the higher tiludronate concentrations increased sGAG release and chondrocyte apoptosis. At the highest tiludronate concentration evaluated, IL-8 gene expression was increased independent of whether rEq IL-1 was present. Conclusions and Clinical Relevance-Tiludronate had biphasic concentration-dependent effects on cartilage explants that were independent of PGE(2) secretion or MMP gene expression. Low tiludronate concentrations had some chondroprotective effects, whereas high tiludronate concentrations were detrimental to equine articular cartilage. Administration of tiludronate intra-articularly to horses may be detrimental, dependent on the dose used. In vivo studies are needed before intra-articular tiludronate administration to horses can be recommended.
Katja F Duesterdieck-Zellmer; Nellie Driscoll; Jesse F Ott
Related Documents :
23684238 - Rough titanium alloys regulate osteoblast production of angiogenic factors.
3678378 - Regulation of cardiac myosin synthesis: studies of rna content in cultured heart cells.
24196298 - In vitro morphogenetic responses and plant regeneration from pepper (capsicum annuum l....
24958548 - In vitro culture and characterization of spermatogonial stem cells on sertoli cell feed...
24874888 - Growth inhibition of the cyanobacterium microcystis aeruginosa and degradation of its m...
133008 - Role of adenosine deaminase in lymphocyte proliferation.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  American journal of veterinary research     Volume:  73     ISSN:  1943-5681     ISO Abbreviation:  Am. J. Vet. Res.     Publication Date:  2012 Oct 
Date Detail:
Created Date:  2012-09-27     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0375011     Medline TA:  Am J Vet Res     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1530-9     Citation Subset:  IM    
Department of Clinical Sciences, College of Veterinary Medicine, Oregon State University, Corvallis, OR 97331.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Mechanical properties of isolated loops of nylon leader material, polyethylene cord, and polyethylen...
Next Document:  Evaluation of experimental impact injury for inducing post-traumatic osteoarthritis in the metacarpo...